MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 134 filers reported holding MERSANA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $165 | +139.1% | 40,034 | +239.3% | 0.00% | 0.0% |
| Q4 2022 | $69 | -100.0% | 11,799 | -92.5% | 0.00% | -92.9% |
| Q3 2022 | $1,064,000 | +801.7% | 157,411 | +516.6% | 0.01% | +1300.0% |
| Q2 2022 | $118,000 | -89.3% | 25,529 | -90.8% | 0.00% | -92.9% |
| Q1 2022 | $1,106,000 | +485.2% | 277,089 | +811.1% | 0.01% | +600.0% |
| Q4 2021 | $189,000 | -34.1% | 30,411 | +43.8% | 0.00% | -33.3% |
| Q2 2021 | $287,000 | -67.0% | 21,147 | -35.3% | 0.00% | -62.5% |
| Q4 2020 | $870,000 | +3.9% | 32,704 | -27.3% | 0.01% | -52.9% |
| Q3 2020 | $837,000 | +191.6% | 44,958 | -17.5% | 0.02% | -19.0% |
| Q1 2019 | $287,000 | – | 54,498 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |